Related Experiment Video
Updated: Jan 9, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
[Venous thromboembolism : therapeutic strategies]
Sophie Ammane1, Enrica Porceddu1, Sanjiv Keller1
1Service d'angiologie, Département cœur-vaisseaux, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Venous thromboembolism (VTE) management relies on anticoagulant therapy. This review covers current knowledge on VTE treatment duration and strategies, focusing on recurrence risk and long-term outcomes.
Area of Science:
- Cardiology
- Hematology
- Pulmonary Medicine
Background:
- Venous thromboembolism (VTE) is a significant cause of illness and death.
- VTE presents risks of recurrence and long-term complications like chronic thromboembolic pulmonary hypertension and post-thrombotic syndrome.
Purpose of the Study:
- To summarize current knowledge on anticoagulant therapy duration for VTE.
- To review available treatment strategies for managing VTE.
Main Methods:
- Literature review of recently published studies on VTE management.
- Synthesis of evidence regarding anticoagulant therapy duration and treatment options.
Main Results:
- Anticoagulant therapy is central to VTE management.
- Current research informs decisions on treatment duration and strategy.
Conclusions:
- Optimal duration of anticoagulant therapy for VTE requires careful consideration of individual risk factors.
- Evidence-based treatment strategies are crucial for improving VTE outcomes and preventing complications.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care

